{
    "Trade/Device Name(s)": [
        "Borrelia burgdorferi B31 IgM Line Blot Test Kit"
    ],
    "Submitter Information": "Gold Standard Diagnostics",
    "510(k) Number": "K113846",
    "Predicate Device Reference 510(k) Number(s)": [
        "K951709"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LSR"
    ],
    "Summary Letter Date": "December 28, 2011",
    "Summary Letter Received Date": "March 8, 2012",
    "Submission Date": "May 27, 2012",
    "Regulation Number(s)": [
        "21 CFR 866.3830"
    ],
    "Regulation Name(s)": [
        "Treponema pallidum treponemal test reagents"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "immunology"
    ],
    "Analyte(s)": [
        "IgM antibodies to Borrelia burgdorferi sensu stricto (B31)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Line blot",
        "Western blot",
        "Enzyme immunoassay"
    ],
    "Methodologies": [
        "Qualitative immunoassay",
        "Western blot"
    ],
    "Submission Type(s)": [
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Gold Standard Diagnostics Borrelia burgdorferi B31 IgM Line Blot Test Kit for qualitative detection of IgM antibodies to B. burgdorferi in human serum",
    "Indications for Use Summary": "Qualitative detection of IgM antibodies to B. burgdorferi sensu stricto (B31) in human serum for samples found positive or equivocal by ELISA or IFA, providing supportive evidence of infection",
    "fda_folder": "Microbiology"
}